Completion of a significant clinical study

Completion of a significant clinical study - Axcellant

Completion of a significant clinical study

  1. lut 01, 2024

Our team at Axcellant is proud to announce the completion of a significant Post-Market Clinical Follow-up study.

This study was meticulously designed to evaluate the performance and safety of a novel wound dressing technology in real-world settings. Emphasizing safety and performance, the study aimed to gather comprehensive data on the expected outcomes and to vigilantly monitor for any expected and unexpected adverse events. The study was completed ahead of schedule.

The success of this study is a testament to the collaborative effort of our dedicated team and the participating medical professionals, who navigated these challenges with expertise and commitment.

If you are interested in any type of medical devices study, please do not hesitate to contact us.

Read more

Axcellant partners with Prometheus MedTech.AI to accelerate AI-powered cardiac diagnostics

We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…

Axcellant at EANM 2025: What We Brought Back from Barcelona

The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…

Radioisotopes in Medicine: Clinical Applications, Safety, and Regulatory Considerations

The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…